April 23, 2015
Accuray today announced the introduction of Delivery Analysis software for the TomoTherapy System.
With Delivery Analysis software, users gain unprecedented access to TomoTherapy treatment delivery information, via
MVCT detector data. The data is presented in a customizable dashboard, allowing users to quantitatively compare
planned and measured procedures – and easily view trends in patient delivery.
Specifically, Delivery Analysis facilitates:
• Prior to treatment comparisons of measured MLC performance to plan, including 3D dose calculation (GPU) in
patient planning CT
• During treatment assessments of the consistency of exit fluence data from fraction to fraction, including
trending of differences
Combined, these capabilities provide enhanced confidence in system performance before every treatment, and
actionable insights to ensure all treatments stay on track.
SEE DELIVERY ANALYSIS IN ACTION
Delivery Analysis software will be featured in the Accuray booth (#2100) at ESTRO 2015, which runs April 24-27, in
Barcelona. If you are attending ESTRO, please visit the booth for a demonstration, and plan to attend the below AERO
Academy session.
Saturday, April 25, 2015, 12:30 – 12:55 pm
Delivery Analysis: Using Exit-Detector Data to View Trends in Patient Delivery
Dylan Casey, Accuray Incorporated, Madison, Wisconsin, United States
For those not attending ESTRO, please know all AERO Academy sessions will be posted to the Education section as they
become available.
For more information and a demonstration of Delivery Analysis software, please contact your sales representative.
Notes: Delivery Analysis is intended to support existing quality assurance practices. It does not replace quality assurance.
Delivery Analysis requires TomoTherapy® H™ Series software version 2.0.5 or later (Hi-Art® version 5.0.5 or later).